A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia:: A prospective study

被引:61
作者
Gaïni, Shahin
Koldkjær, Ole G.
Moller, Holger J.
Pedersen, Court
Pedersen, Svend S.
机构
[1] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense C, Denmark
[2] Sonderborg Hosp, Dept Clin Biochem, Sonderborg, Denmark
[3] AS NBG Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark
来源
CRITICAL CARE | 2007年 / 11卷 / 04期
关键词
D O I
10.1186/cc5967
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction High-mobility group box-1 protein (HMGB1) has been known as a chromosomal protein for many years. HMGB1 has recently been shown to be a proinflammatory cytokine with a role in the immunopathogenesis of sepsis. Lipopolysaccharide-binding protein (LBP) has a central role in the innate immune response when the host is challenged by bacterial pathogens. Procalcitonin (PCT) has been suggested as a marker of severe bacterial infections and sepsis. The aim of the present study was to investigate levels of HMGB1, LBP and PCT in a well-characterised sepsis cohort. The study plan included analysis of the levels of the inflammatory markers in relation to the severity of infection, to the prognosis and to the ability to identify patients with bacteraemia. Methods Patients suspected of having severe infections and admitted to a department of internal medicine were included in a prospective manner. Demographic data, comorbidity, routine biochemistry, microbiological data, infection focus, severity score and mortality on day 28 were recorded. Plasma and serum were sampled within 24 hours after admission. Levels of all studied markers (HMGB1, LBP, PCT, IL-6, C-reactive protein, white blood cell count and neutrophils) were measured with commercially available laboratory techniques. Results A total of 185 adult patients were included in the study; 154 patients fulfilled our definition of infection. Levels of HMGB1, LBP and PCT were higher in infected patients compared with a healthy control group (P < 0.0001). Levels of HMGB1, LBP and PCT were higher in the severe sepsis group compared with the sepsis group (P < 0.01). No differences were observed in levels of the inflammatory markers in fatal cases compared with survivors. Levels of all studied markers were higher in bacteraemic patients compared with nonbacteraemic patients (P < 0.05). PCT performed best in a receiver-operator curve analysis discriminating between bacteraemic and nonbacteraemic patients (P < 0.05). HMGB1 correlated to LBP, IL-6, C-reactive protein, white blood cell count and neutrophils (P < 0.001). LBP correlated to PCT, IL-6 and C-reactive protein (P < 0.001). Conclusion Levels of HMGB1, PCT and LBP were higher in infected patients compared with those in healthy controls, and levels were higher in severe sepsis patients compared with those in sepsis patients. Levels of all studied inflammatory markers (HMGB1, LBP, PCT, IL-6) and infection markers (C-reactive protein, white blood cell count, neutrophils) were elevated among bacteraemic patients. PCT performed best as a diagnostic test marker for bacteraemia.
引用
收藏
页数:10
相关论文
共 44 条
[31]  
Rintala EM, 2001, SCAND J CLIN LAB INV, V61, P523
[32]   Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved [J].
Schröder, NWJ ;
Morath, S ;
Alexander, C ;
Hamann, L ;
Hartung, T ;
Zähringer, U ;
Göbel, UB ;
Weber, JR ;
Schumann, RR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) :15587-15594
[33]   A novel acute-phase marker: Lipopolysaccharide binding protein (LBP) [J].
Schumann, RR ;
Zweigner, J .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1999, 37 (03) :271-274
[34]   Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock [J].
Sundén-Cullberg, J ;
Norrby-Teglund, A ;
Rouhiainen, A ;
Rauvala, H ;
Herman, G ;
Tracey, KJ ;
Lee, ML ;
Andersson, J ;
Tokics, L ;
Treutiger, CJ .
CRITICAL CARE MEDICINE, 2005, 33 (03) :564-573
[35]   Procalcitonin used as a marker of infection in the intensive care unit [J].
Ugarte, H ;
Silva, E ;
Mercan, D ;
De Mendonça, A ;
Vincent, JL .
CRITICAL CARE MEDICINE, 1999, 27 (03) :498-504
[36]   Factors masking HMGB1 in human serum and plasma [J].
Urbonaviciute, Vilma ;
Fuernrohr, Barbara G. ;
Weber, Christian ;
Haslbeck, Martin ;
Wilhelm, Sabine ;
Herrmann, Martin ;
Voll, Reinhard E. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 81 (01) :67-74
[37]   The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure [J].
Vincent, JL ;
Moreno, R ;
Takala, J ;
Willatts, S ;
DeMendonca, A ;
Bruining, H ;
Reinhart, CK ;
Suter, PM ;
Thijs, LG .
INTENSIVE CARE MEDICINE, 1996, 22 (07) :707-710
[38]   Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein [J].
von Lilienfeld-Toal, M ;
Dietrich, MP ;
Glasmacher, A ;
Lehmann, L ;
Breig, P ;
Hahn, C ;
Schmidt-Wolf, IGH ;
Marklein, G ;
Schroeder, S ;
Stuber, F .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (07) :539-544
[39]   HMG-1 as a late mediator of endotoxin lethality in mice [J].
Wang, HC ;
Bloom, O ;
Zhang, MH ;
Vishnubhakat, JM ;
Ombrellino, M ;
Che, JT ;
Frazier, A ;
Yang, H ;
Ivanova, S ;
Borovikova, L ;
Manogue, KR ;
Faist, E ;
Abraham, E ;
Andersson, J ;
Andersson, U ;
Molina, PE ;
Abumrad, NN ;
Sama, A ;
Tracey, KJ .
SCIENCE, 1999, 285 (5425) :248-251
[40]   HMGB1 as a late mediator of lethal systemic inflammation [J].
Wang, HH ;
Yang, H ;
Czura, CJ ;
Sama, AE ;
Tracey, KJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (10) :1768-1773